Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Adcock Ingram Holdings ZAR 479.08M 106.67M 2024-06
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 2.31B 182M 2024-12
Arrowhead Research USD -161412000 791K 2024-12
Biogen USD 441.4M 24.4M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Celltrion KRW 207.69B 135.2B 2024-09
Cspc Pharmaceutical CNY 985M 796.94M 2024-09
Dianthus Therapeutics USD -29900000 7.7M 2024-09
Gilead Sciences USD 2.45B 1.56B 2024-12
GlaxoSmithKline GBP 696M 507M 2024-12
Incyte USD 301.51M 155.43M 2024-12
Ionis Pharmaceuticals USD -110823000 37.83M 2024-12
Kangmei Pharma CNY -58945310 67.51M 2024-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 37.16M 17.88M 2024-06
Malin Corporation EUR -700000 1.6M 2024-06
Moderna USD -1246000000 1.18B 2024-12
Organigram Holdings CAD -11305000 11.59M 2024-12
Pharma Mar EUR 4.89M 588K 2024-12
Qiagen NV USD 144.16M 14.73M 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Sartorius EUR 68.2M 38.1M 2024-09
Sino Biopharmaceutical CNY 1.73B 948.23M 2024-06
Tilray USD -42218000 5.65M 2024-11
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12
Zz Pientze Pharmaceu 1.13B 233.14M 2024-09



Moderna Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.